Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000902664-25-003656·Slate Path Capital LP
Schedule 13G ownership disclosure
Tvardi Therapeutics Inc
Common stock, par value $0.001 per share · CUSIP: 140755307
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Slate Path Capital LP
Shares: 704,118.00 · Class: 7.5%
- David Greenspan
Shares: 704,118.00 · Class: 7.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-003656
- Form type
- SCHEDULE 13G
- Filer
- Slate Path Capital LP
- CIK
- CIK 1559706
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership